Transcell Biologics has registered trademarks and patents with USPTO/WIPO relating to technologies of Stem cell unique sourcing, processing, methods of clinical preparations and presentations, cryopreservation methods retaining therapeutic values claims.
The standard operating procedures at the lab are unique and with proven reproducible data.
Invited Review Article on Drug Discovery in Chemical Biology Journal, Cell Press, 2014
Dravida S, Krishna L (2014) Stem Cell – Implant Composites for Periodontal Tissue Revival. J Cell Sci Ther 5:183. doi: 10.4172/2157-7013.1000183
Rethinking Drug Discovery | Research Development
Chapter Stem Cell Therapy for Organ Failure, pp 173-177, Date: 12 November 2014, Springer.com; Mesenchymal Stem Cell Treatment Option to Manage Autoimmune Disorders: A Technically Feasible Integration. Subadra Dravida Affiliated with Tran-Scell Biologics Pvt. Ltd. R. Indarapu
Mesenchymal Progenitor Cells from Different Sources and their Potential to Differentiate In Vitro into Muscle Cells; Ranjith Kumar Indarapu, Leela Krishna and Subhadra Dravida; Cell Dev Biol 2013, 2:3
International Journal of Stem Cell Research & Therapy, 2012 - Laser Irradiation on Human Umbilical Cord Stroma Derived Mesenchymal Stem Cells for Regenerative Medicine Applications in vitro Study